Matthew Herper is a science and medicine contributing writer at Forbes.com. He has just written a series of posts themed as "Gene Week", focusing on advances in genomics. One of the most provocative, "Why You Can’t Have Your $1,000 Genome", focuses on the hidden costs of interpretation and high-coverage necessary for clinical use of genome data.
↧